Zenas BioPharma (ZBIO) Revenue & Revenue Breakdown
Zenas BioPharma Revenue Highlights
Latest Revenue (Y)
$5.00M
Latest Revenue (Q)
$10.00M
Zenas BioPharma Revenue by Period
Zenas BioPharma Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $5.00M | -90.00% |
| 2023-12-31 | $50.00M | 100.00% |
| 2022-12-31 | - | - |
Zenas BioPharma generated $5.00M in revenue during NA 2024, up -90.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Zenas BioPharma Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | $10.00M | 100.00% |
| 2024-12-31 | $5.00M | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | -100.00% |
| 2023-09-30 | $50.00M | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | - |
Zenas BioPharma generated $10.00M in revenue during Q1 2025, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Zenas BioPharma Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| NVAX | Novavax | $682.16M | $70.44M |
| WVE | Wave Life Sciences | $108.30M | $7.61M |
| AMLX | Amylyx Pharmaceuticals | $87.37M | - |
| SNDX | Syndax Pharmaceuticals | $23.68M | $45.87M |
| RLAY | Relay Therapeutics | $10.01M | - |
| ZBIO | Zenas BioPharma | $5.00M | $10.00M |
| UPB | Upstream Bio | $2.37M | $683.00K |
| INBX | Inhibrx Biosciences | $200.00K | - |
| NTLA | Intellia Therapeutics | - | $13.78M |
| TRVI | Trevi Therapeutics | - | - |
| ORIC | ORIC Pharmaceuticals | - | - |